Charles Schwab’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-895,664
| Closed | -$118M | – | 3621 |
|
|
2025
Q1 | $118M | Sell |
895,664
-10,982
| -1% | -$1.37M | 0.02% | 574 |
|
|
2024
Q4 | $75.7M | Buy |
906,646
+1,737
| +0.2% | +$143K | 0.01% | 819 |
|
|
2024
Q3 | $66.2M | Sell |
904,909
-16,160
| -2% | -$1.21M | 0.01% | 913 |
|
|
2024
Q2 | $63.1M | Sell |
921,069
-84,779
| -8% | -$5.88M | 0.01% | 900 |
|
|
2024
Q1 | $69.6M | Buy |
1,005,848
+12,035
| +1% | +$827K | 0.02% | 803 |
|
|
2023
Q4 | $71.2M | Buy |
993,813
+18,899
| +2% | +$1.09M | 0.02% | 740 |
|
|
2023
Q3 | $50.8M | Buy |
974,914
+259,424
| +36% | +$15.1M | 0.01% | 869 |
|
|
2023
Q2 | $45.3M | Buy |
715,490
+16,101
| +2% | +$1M | 0.01% | 914 |
|
|
2023
Q1 | $37.9M | Buy |
699,389
+2,585
| +0.4% | +$125K | 0.01% | 1022 |
|
|
2022
Q4 | $36.9M | Buy |
696,804
+16,345
| +2% | +$819K | 0.01% | 1002 |
|
|
2022
Q3 | $31.7M | Buy |
680,459
+54,695
| +9% | +$2.86M | 0.01% | 1058 |
|
|
2022
Q2 | $35.7M | Buy |
625,764
+18,027
| +3% | +$1.02M | 0.01% | 978 |
|
|
2022
Q1 | $37.2M | Buy |
607,737
+89,260
| +17% | +$4.64M | 0.01% | 1076 |
|
|
2021
Q4 | $27.1M | Buy |
518,477
+8,977
| +2% | +$377K | 0.01% | 1341 |
|
|
2021
Q3 | $19M | Buy |
509,500
+18,487
| +4% | +$643K | 0.01% | 1632 |
|
|
2021
Q2 | $20M | Buy |
491,013
+15,879
| +3% | +$587K | 0.01% | 1585 |
|
|
2021
Q1 | $16.1M | Buy |
475,134
+17,172
| +4% | +$596K | 0.01% | 1679 |
|
|
2020
Q4 | $14.6M | Buy |
457,962
+14,589
| +3% | +$383K | 0.01% | 1626 |
|
|
2020
Q3 | $11.4M | Buy |
443,373
+77,997
| +21% | +$1.78M | 0.01% | 1604 |
|
|
2020
Q2 | $9.38M | Buy |
365,376
+26,090
| +8% | +$528K | ﹤0.01% | 1692 |
|
|
2020
Q1 | $5.21M | Buy |
339,286
+60,162
| +22% | +$1.31M | ﹤0.01% | 1810 |
|
|
2019
Q4 | $9.58M | Buy |
279,124
+5,169
| +2% | +$62K | 0.01% | 1690 |
|
|
2019
Q3 | $2.05M | Buy |
273,955
+2,675
| +1% | +$25.6K | ﹤0.01% | 2369 |
|
|
2019
Q2 | $3.52M | Buy |
271,280
+3,940
| +1% | +$50.5K | ﹤0.01% | 2140 |
|
|
2019
Q1 | $3.26M | Buy |
267,340
+12,289
| +5% | +$157K | ﹤0.01% | 2182 |
|
|
2018
Q4 | $2.91M | Sell |
255,051
-3,244
| -1% | -$52.4K | ﹤0.01% | 2180 |
|
|
2018
Q3 | $5.61M | Buy |
258,295
+15,118
| +6% | +$316K | ﹤0.01% | 1983 |
|
|
2018
Q2 | $4.3M | Buy |
243,177
+15,379
| +7% | +$312K | ﹤0.01% | 2080 |
|
|
2018
Q1 | $4.8M | Buy |
227,798
+6,357
| +3% | +$124K | ﹤0.01% | 1969 |
|
|
2017
Q4 | $3.21M | Buy |
221,441
+88,258
| +66% | +$1.36M | ﹤0.01% | 2134 |
|
|
2017
Q3 | $2.1M | Sell |
133,183
-1,102
| -0.8% | -$16.2K | ﹤0.01% | 2268 |
|
|
2017
Q2 | $1.67M | Sell |
134,285
-3,690
| -3% | -$42.8K | ﹤0.01% | 2282 |
|
|
2017
Q1 | $2.24M | Buy |
137,975
+7,335
| +6% | +$106K | ﹤0.01% | 2169 |
|
|
2016
Q4 | $1.97M | Buy |
130,640
+6,709
| +5% | +$94.7K | ﹤0.01% | 2193 |
|
|
2016
Q3 | $1.89M | Buy |
123,931
+12,984
| +12% | +$525K | ﹤0.01% | 2156 |
|
|
2016
Q2 | $4.31M | Buy |
110,947
+13,782
| +14% | +$495K | 0.01% | 1664 |
|
|
2016
Q1 | $2.7M | Buy |
97,165
+2,037
| +2% | +$67.9K | ﹤0.01% | 1891 |
|
|
2015
Q4 | $5.12M | Buy |
95,128
+30,279
| +47% | +$1.53M | 0.01% | 1508 |
|
|
2015
Q3 | $2.6M | Sell |
64,849
-8,274
| -11% | -$270K | ﹤0.01% | 1915 |
|
|
2015
Q2 | $2.34M | Buy |
73,123
+8,607
| +13% | +$218K | ﹤0.01% | 1999 |
|
|
2015
Q1 | $1.54M | Buy |
64,516
+3,817
| +6% | +$85.5K | ﹤0.01% | 2199 |
|
|
2014
Q4 | $1.07M | Buy |
60,699
+15,768
| +35% | +$246K | ﹤0.01% | 2319 |
|
|
2014
Q3 | $617K | Buy |
44,931
+1,219
| +3% | +$18.3K | ﹤0.01% | 2512 |
|
|
2014
Q2 | $737K | Buy |
43,712
+24,716
| +130% | +$408K | ﹤0.01% | 2471 |
|
|
2014
Q1 | $346K | Buy |
+18,996
| New | +$343K | ﹤0.01% | 2741 |
|
Other funds holding ITCI
KIM
HNB